Sustainable co2-based biomolecule manufacturing platform
Airobes has developed a biomanufacturing platform that converts captured CO2 into high-value biomolecules using algae and microbial fermentation. This sustainable approach reduces reliance on petrochemical feedstocks, offering applications in skincare and cosmetics.
Overview
Airobes presents a pioneering biomanufacturing platform designed to transform captured CO2 into valuable biomolecules. This eco-friendly system reduces dependence on petrochemical and agricultural feedstocks by utilizing carbon captured from the environment. The two-stage process begins with algae that capture carbon and produce lipid-rich biomass, distinct from the food chain. Subsequently, this biomass feeds into engineered microbial fermentation systems capable of generating a variety of bio-based molecules such as recombinant proteins and growth factors. These molecules have significant potential in the skincare, cosmetics, and consumer goods industries, promoting sustainability and circular manufacturing principles.
Technical specifications
Key features:
- Algae-based carbon fixation: Efficiently captures and converts CO2 into intermediates and lipid-rich biomass.
- Engineered microbial fermentation: Utilizes these intermediates to produce recombinant proteins and other molecules.
- Sustainability: Avoids approximately 60 grams of CO2 emissions per liter of bacterial culture.
- Applications: Ideal for skincare, cosmetics, and other consumer products, with future potential in surfactants and personal care ingredients.
Technology readiness level
Currently at Technology Readiness Level 5, the platform has been proven in relevant environments. Airobes is actively seeking pilot and trial engagements to further validate and scale up the technology, focusing on ingredient evaluation and commercial feasibility. The company is prepared to develop proof-of-concept products within three months, offering a clear path to future supply relationships.
About Airobes, LLC
Airobes is a biotechnology company that converts captured carbon dioxide into a carbon feedstock for bacterial fermentation, enabling the production of recombinant proteins. The company uses algae to metabolically convert CO2, substituting traditional, emission-intensive sugars with a more sustainable and cost-effective alternative. This technology is designed to be source-agnostic, capable of utilizing CO2 captured directly from the air or from industrial sources, thereby advancing a circular bioeconomy.
By leveraging captured CO2 as a valuable resource rather than an waste stream, Airobes provides recombinant proteins for industries including pharmaceuticals, biotechnology research, cosmetics, and agriculture. The company’s business model focuses on product value, allowing partners to retain ownership of tax incentives and credits. This approach aims to provide scalable and consistent biomanufacturing solutions while contributing to net-zero goals.
delivered to your inbox.